Login

A Financial Analyst at SilverStone Group, Inc. holding a Chemistry bachelor's degree and an MBA from Creighton University. 00:10:00

Share On Facebook Share On Twitter

Karan Keith Agarwal - Founder | CEO - Silverstone Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Building Trust Through Transparency: Carlos Romero on Catering to azValor’s Institutional Clients and the Benefits for Retail Investors
00:10:00
solve problems and multiply the benefits of capitalism for everyone while reducing its cost|Dr. Kiersten Stead,Managing Partner, DCVC Bio,DCVC
00:10:00
Instalco CEO Discusses Resilient Growth, M&A Pipeline, and Margin Challenges in Q2 Report Interview | Robin Boheman - Managing Director of Instalco
00:10:00
Two Decades of Financial Expertise: Wealth Management Insights from Standard Chartered | John Lee - Head of Wealth Management, Standard Chartered
00:10:00
Southern Gold: Focused Growth and Investor Value - Insights from One-to-One Mining Conference
00:10:00
Emily Roland, co-chief investment strategist at John Hancock Investment Management, discusses the latest market trends on 'Squawk Box.'
00:10:00
Exploring Geophysical Data and Resource Potential in Northern Territory: Insights from the Geological Survey Presentation
00:10:00
From Skeptic to Systematic: Transforming Company Culture for Growth and Success|CEO, Zenvia Inc
00:10:00
The mission to digitise, democratise, and decarbonise supply chains|Shereen Zarkani,Managing Partner and Head of Maersk Growth,Maersk Growth
00:10:00
Unlocking Potential: Ventura Gold (TSX: RNCH) Explores Centa Daniella Gold Project in Sierra Madre Occidental
00:10:00
CEO Leslie Hill Discusses Company's Fiscal Outlook and Strategic Goals | Leslie Hill, CEO ,  Record Currency Management.
00:10:00
"Howard Marks on Oaktree Capital's Investment Philosophy and Future Outlook: An In-Depth Discussion on Asset TV"

© 2017 - Neuhu+